Founded in 1998 as Clinical Research Intermed GmbH and acquired by Velocity Clinical Research in 2023, the experienced team at Velocity’s dedicated research site in Wiesbaden conducts clinical trials across many areas of medicine, including chronic pain, pulmonology, the central nervous system (CNS), general medicine, and vaccines.
The Wiesbaden team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.
Now Enroling in Wiesbaden
Velocity is enroling participants for clinical trials in Wiesbaden for the following conditions:
- Asthma
- Chronic Lower Back Pain
- COPD
- Depression
- Diabetic Neuropathy
- Flu Vaccine
- Migraine
- Smoking Cessation with COPD